LITH (BioELife) Total Stockholders Equity: $0.01 Mil (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BioELife Total Stockholders Equity?

BioELife LITH -99.00% Total Stockholders Equity is $0.01 Mil as of Sep. 2019.

BioELife's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $0.01 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioELife's Book Value per Share for the quarter that ended in Sep. 2019 was $0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioELife's Debt-to-Equity for the quarter that ended in Sep. 2019 was 0.00.


BioELife  (OTCPK:LITH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioELife's Book Value per Share for the quarter that ended in Sep. 2019 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioELife's Debt-to-Equity for the quarter that ended in Sep. 2019 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioELife Total Stockholders Equity Related Terms


BioELife Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for BioELife's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioELife Total Stockholders Equity Chart

BioELife Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.37 -0.22 -0.29 -0.07 -0.33

BioELife Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 -0.33 -0.25 0.06 0.01
What does a Total Stockholders Equity of $0.01 Mil mean?
BioELife (LITH) has a Total Stockholders Equity of $0.01 Mil as of Sep. 2019. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for BioELife and its competitors.
Is BioELife's Total Stockholders Equity too high?
BioELife's current Total Stockholders Equity is $0.01 Mil.
How does BioELife's Total Stockholders Equity compare to BSPK and PCYN?
BioELife's Total Stockholders Equity of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for BioELife and its competitors. BioELife's current Total Stockholders Equity is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioELife stock overvalued right now?
BioELife (LITH) has a current Total Stockholders Equity of $0.01 Mil. The current Total Stockholders Equity is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For BioELife (LITH), the current Total Stockholders Equity is $0.01 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioELife Business Description

Address 12340 Seal Beach Boulevard, Suite B-190, Seal Beach, CA, USA, 90740
BioELife Corp is engaged in the manufacturing and distribution of Cannabinoid products. The company's product portfolio includes Combo Adult Gummies with Chirorub; Combo Tincture with Chirorub; Intensive Relief Rub; Tinctures; Adult Gummies; Premium Pre-Rolls; and Flower.